Invivyd (IVVD) Non-Current Deferred Tax Liability (2023 - 2025)

Invivyd (IVVD) posted Non-Current Deferred Tax Liability of $719000.0 for Q4 2025, down 99.22% on a QoQ basis from $92.0 million in Q4 2024, and down 99.22% year-over-year from $92.0 million in Q4 2024.

Invivyd (IVVD) Non-Current Deferred Tax Liability (2023 - 2025) Analysis & Trends

Invivyd's Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $719000.0 for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 99.22% year-over-year to $719000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $719000.0 (down 99.22% YoY) and the FY2025 annual result came in at $719000.0, down 99.22% from the prior year.
  • Non-Current Deferred Tax Liability was $719000.0 for Q4 2025 at Invivyd, down from $92.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $92.0 million in Q4 2024 and bottomed at $719000.0 in Q4 2025.
  • A 3-year average of $55.6 million and a median of $74.1 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability grew 24.07% — and 2025, when it plunged 99.22%.
  • Invivyd's Non-Current Deferred Tax Liability stood at $74.1 million in 2023, then increased by 24.07% to $92.0 million in 2024, then plunged by 99.22% to $719000.0 in 2025.
  • Business Quant data shows IVVD's Non-Current Deferred Tax Liability at $719000.0 in Q4 2025, $92.0 million in Q4 2024, and $74.1 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Invivyd 104.07 Mn -122.62 Mn 16.07 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 719,000.00
Dec 31, 2025 719,000.00
Dec 31, 2024 91.95 Mn
Dec 31, 2024 91.95 Mn
Dec 31, 2023 74.12 Mn
Dec 31, 2023 74.12 Mn